← Back to Search

Dietary Supplement

Carbohydrate Intake for Glycogen Storage Disease

N/A
Waitlist Available
Led By Rajavel Elango, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children and adults who currently free from any concurrent illness such as fever or cold
Children and adults who have no medical conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine how well different carbohydrates are digested by people with GSD I and healthy controls.

Who is the study for?
This trial is for healthy adults aged 19-35, and children and adults with Glycogen Storage Disease (GSD I) aged 5-18. Participants must have no medical conditions or current illnesses like fever or cold.
What is being tested?
The study tests how different carbohydrates, including a modified cornstarch called Glycosade®, affect blood glucose levels in people with GSD I compared to healthy individuals.
What are the potential side effects?
Since the interventions involve regular carbohydrate intake, side effects may be minimal but could include digestive discomfort or changes in blood sugar levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently not suffering from any illnesses like a fever or cold.
Select...
I have no existing medical conditions.
Select...
I am between 19 and 35 years old and have been diagnosed with GSD I.
Select...
I am a healthy child aged between 5 and 18.
Select...
I am currently not suffering from any illnesses like a fever or cold.
Select...
I am between 5 and 18 years old and have been diagnosed with GSD I.
Select...
I am a healthy adult between 19 and 35 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Glucose oxidation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Glucose intakeExperimental Treatment1 Intervention
Experiment 1: study day 1- single oral dose of glucose study day 2- single oral dose of glucose with U-13C-glucose
Group II: Carbohydrates intakeExperimental Treatment1 Intervention
Experiment 2: study day 1-single oral dose of uncooked cornstarch study day 2-single oral dose of Glycosade®
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glucose intake
2016
N/A
~40

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,466 Previous Clinical Trials
2,485,418 Total Patients Enrolled
Saudi Arabian Cultural Bureau, OttawaUNKNOWN
1 Previous Clinical Trials
4 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,518,035 Total Patients Enrolled
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top